264 related articles for article (PubMed ID: 33640178)
1. Oral candidiasis in human immunodeficiency virus-infected patients under highly active antiretroviral therapy.
Shekatkar M; Kheur S; Gupta AA; Arora A; Raj AT; Patil S; Khan SS; Desai A; Carroll WB; Awan KH
Dis Mon; 2021 Sep; 67(9):101169. PubMed ID: 33640178
[TBL] [Abstract][Full Text] [Related]
2. Reviewing the oral pigmented lesions of human immunodeficiency virus with emphasis on the effect of highly active antiretroviral therapy.
Varadarajan S; Balaji TM; Kumar S N; Indu Bharkavi SK; Thangavel G; Raj AT; Patil S; Al-Iryani GM; Ali FM; Awan KH
Dis Mon; 2021 Sep; 67(9):101167. PubMed ID: 33640179
[TBL] [Abstract][Full Text] [Related]
3. Necrotizing periodontal diseases in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: A review.
Balaji TM; Varadarajan S; Sujatha G; Muruganandhan J; Shanmugapriya R; Raj AT; Patil S; Fageeh HI; Fageeh HN; Malik NH; Awan KH
Dis Mon; 2021 Sep; 67(9):101168. PubMed ID: 33640175
[TBL] [Abstract][Full Text] [Related]
4. The changing role of HIV-associated oral candidiasis in the era of HAART.
Patuwo C; Young K; Lin M; Pardi V; Murata RM
J Calif Dent Assoc; 2015 Feb; 43(2):87-92. PubMed ID: 25868223
[TBL] [Abstract][Full Text] [Related]
5. Clinical Oral Condition Analysis and the Influence of Highly Active Antiretroviral Therapy on Human Salivary Microbial Community Diversity in HIV-Infected/AIDS Patients.
Cao P; Zhang Y; Dong G; Wu H; Yang Y; Liu Y
Front Cell Infect Microbiol; 2022; 12():937039. PubMed ID: 35846778
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of T-cell subsets and their relationship with oral and systemic opportunistic infections in HIV/AIDS patients during the first year of HAART in Guangxi, China.
Zhang L; Huang Y; Liu Z; Liu W; Qin Q; Tao R
J Med Virol; 2015 Jul; 87(7):1158-67. PubMed ID: 25777553
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of oral candidiasis in HIV/AIDS children in highly active antiretroviral therapy era. A literature analysis.
Gaitán-Cepeda LA; Sánchez-Vargas O; Castillo N
Int J STD AIDS; 2015 Aug; 26(9):625-32. PubMed ID: 25156369
[TBL] [Abstract][Full Text] [Related]
8. Most common oral manifestations in pediatric patients HIV positive and the effect of highly active antiretroviral therapy.
Araújo JF; Oliveira AEF; Carvalho HLCC; Roma FRVO; Lopes FF
Cien Saude Colet; 2018 Jan; 23(1):115-122. PubMed ID: 29267817
[TBL] [Abstract][Full Text] [Related]
9. Effect of prolonged HAART on oral colonization with Candida and candidiasis.
Yang YL; Lo HJ; Hung CC; Li Y
BMC Infect Dis; 2006 Jan; 6():8. PubMed ID: 16423306
[TBL] [Abstract][Full Text] [Related]
10. Various patterns of oral mucosa candidiasis treatment in HIV patients.
Macura AB; Bort A; Postawa-Kłosińska B; Mach T
Folia Med Cracov; 2002; 43(1-2):69-77. PubMed ID: 12815800
[TBL] [Abstract][Full Text] [Related]
11. Candidiasis-associated hemophagocytic lymphohistiocytosis in a patient infected with human immunodeficiency virus.
Bhatia S; Bauer F; Bilgrami SA
Clin Infect Dis; 2003 Dec; 37(11):e161-6. PubMed ID: 14614689
[TBL] [Abstract][Full Text] [Related]
12. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: a new face of oral AIDS?
Ceballos-Salobreña A; Gaitán-Cepeda LA; Ceballos-Garcia L; Lezama-Del Valle D
AIDS Patient Care STDS; 2000 Dec; 14(12):627-35. PubMed ID: 11119429
[TBL] [Abstract][Full Text] [Related]
13. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997.
San-Andrés FJ; Rubio R; Castilla J; Pulido F; Palao G; de Pedro I; Costa JR; del Palacio A
Clin Infect Dis; 2003 May; 36(9):1177-85. PubMed ID: 12715314
[TBL] [Abstract][Full Text] [Related]
14. Impact of PI and NNRTI HAART-based therapy on oral lesions of Brazilian HIV-infected patients.
Ortega KL; Vale DA; Magalhães MH
J Oral Pathol Med; 2009 Jul; 38(6):489-94. PubMed ID: 19453845
[TBL] [Abstract][Full Text] [Related]
15. Associations among the use of highly active antiretroviral therapy, oral candidiasis, oral Candida species and salivary immunoglobulin A in HIV-infected children.
Pomarico L; Cerqueira DF; de Araujo Soares RM; de Souza IP; de Araujo Castro GF; Socransky S; Haffajee A; Teles RP
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Aug; 108(2):203-10. PubMed ID: 19615660
[TBL] [Abstract][Full Text] [Related]
16. Oral lesions in Brazilian HIV-infected children undergoing HAART.
Miziara ID; Filho BC; Weber R
Int J Pediatr Otorhinolaryngol; 2006 Jun; 70(6):1089-96. PubMed ID: 16406081
[TBL] [Abstract][Full Text] [Related]
17. Oral Candida colonization and its relation with predisposing factors in HIV-infected children and their uninfected siblings in Brazil: the era of highly active antiretroviral therapy.
Cerqueira DF; Portela MB; Pomarico L; de Araújo Soares RM; de Souza IP; Castro GF
J Oral Pathol Med; 2010 Feb; 39(2):188-94. PubMed ID: 20040023
[TBL] [Abstract][Full Text] [Related]
18. [The incidence of oral candidiasis in patients with human immunodeficiency virus infection/acquired immunodeficiency syndrome from Yunnan, China].
Wen Y; Li C; Pei J; Bai J; Yang X; Duan K
Zhonghua Kou Qiang Yi Xue Za Zhi; 2014 Aug; 49(8):454-8. PubMed ID: 25351215
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women.
Ohmit SE; Sobel JD; Schuman P; Duerr A; Mayer K; Rompalo A; Klein RS;
J Infect Dis; 2003 Jul; 188(1):118-27. PubMed ID: 12825180
[TBL] [Abstract][Full Text] [Related]
20. Opportunistic diseases in HIV-infected patients in Gabon following the administration of highly active antiretroviral therapy: a retrospective study.
Okome-Nkoumou M; Guiyedi V; Ondounda M; Efire N; Clevenbergh P; Dibo M; Dzeing-Ella A
Am J Trop Med Hyg; 2014 Feb; 90(2):211-5. PubMed ID: 24323514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
